共 50 条
- [23] The Authors’ Reply to van Baal et al.: “Pharmacoeconomic Guidelines Should Prescribe Inclusion of Indirect Medical Costs! A Response to Grima et al.” PharmacoEconomics, 2013, 31 : 375 - 376
- [29] In Response to Morgan et al. and Li et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (04): : 1012 - 1013
- [30] Response to Pederson et al. and Chlebowski et al. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (02): : 229 - 230